These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18304966)

  • 21. Can circulating M30 and M65 levels be beneficial markers in the diagnosis and management of patients with complete hydatidiform mole?
    Incebiyik A; Vural M; Camuzcuoglu H; Taskin A; Camuzcuoglu A; Hilali NG; Aksoy N
    Wien Klin Wochenschr; 2016 Dec; 128(Suppl 8):566-571. PubMed ID: 25869758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum profiles of M30, M65 and interleukin-17 compared with C-reactive protein in patients with mild and severe acute pancreatitis.
    Vlachos S; Tsaroucha AK; Konstantoudakis G; Papachristou F; Trypsianis G; Schizas D; Vaos G; Simopoulos C
    J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):911-8. PubMed ID: 25214429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum M65 as a biomarker for metastatic renal cell carcinoma.
    Yildiz I; Sen F; Kilic L; Keskin S; Duranyildiz D; Bilgin E; Disci R; Ekenel M; Darendeliler E; Bavbek S; Basaran M
    Clin Genitourin Cancer; 2013 Sep; 11(3):290-6. PubMed ID: 23391372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of cell death in acute-on-chronic liver failure: a clinico-pathologic-biomarker study.
    Adebayo D; Morabito V; Andreola F; Pieri G; Luong TV; Dhillon A; Mookerjee R; Jalan R
    Liver Int; 2015 Dec; 35(12):2564-74. PubMed ID: 25879577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Caspase-Cleaved Cytokeratin (M30) Indicates Severity of Liver Dysfunction and Predicts Liver Outcome.
    Oweira H; Sadeghi M; Volker D; Mieth M; Zidan A; Khajeh E; Ghamarnejad O; Fonouni H; Weiss KH; Schmidt J; Lahdou I; Mehrabi A
    Ann Transplant; 2018 Jun; 23():393-400. PubMed ID: 29880786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.
    Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A
    J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer.
    Yildiz I; Tas F; Kilic L; Sen F; Saip P; Eralp Y; Keskin S; Karabulut S; Ciftci R; Serilmez M; Yasasever V; Aydiner A
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):437-44. PubMed ID: 23801282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis.
    Bissonnette J; Altamirano J; Devue C; Roux O; Payancé A; Lebrec D; Bedossa P; Valla D; Durand F; Ait-Oufella H; Sancho-Bru P; Caballeria J; Ginès P; Boulanger CM; Bataller R; Rautou PE
    Hepatology; 2017 Aug; 66(2):555-563. PubMed ID: 28120471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer.
    Turk HM; Aliyev A; Celik RS; Seker M; Coban E; Demir T; Baydas T; Kocyigit A
    Curr Probl Cancer; 2020 Feb; 44(1):100497. PubMed ID: 31371034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell Death and Prognosis of Mortality in Alcoholic Hepatitis Patients Using Plasma Keratin-18.
    Woolbright BL; Bridges BW; Dunn W; Olson JC; Weinman SA; Jaeschke H
    Gene Expr; 2017 Nov; 17(4):301-312. PubMed ID: 28770701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating biomarkers of cell death after treatment with the BH-3 mimetic ABT-737 in a preclinical model of small-cell lung cancer.
    Micha D; Cummings J; Shoemaker A; Elmore S; Foster K; Greaves M; Ward T; Rosenberg S; Dive C; Simpson K
    Clin Cancer Res; 2008 Nov; 14(22):7304-10. PubMed ID: 19010845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Circulating Caspase-Cleaved Keratin 18 Fragments (M30) Indicate Short-Term Mortality in Critically Ill Patients.
    Koch A; Yagmur E; Linka J; Schumacher F; Bruensing J; Buendgens L; Herbers U; Koek GH; Weiskirchen R; Trautwein C; Tacke F
    Dis Markers; 2018; 2018():8583121. PubMed ID: 30069276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokeratin-18 fragments predict treatment response and overall survival in gastric cancer in a randomized controlled trial.
    Nagel M; Schulz J; Maderer A; Goepfert K; Gehrke N; Thomaidis T; Thuss-Patience PC; Al-Batran SE; Hegewisch-Becker S; Grimminger P; Galle PR; Möhler M; Schattenberg JM
    Tumour Biol; 2018 Mar; 40(3):1010428318764007. PubMed ID: 29534639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caspase-cleaved cytokeratin 18 fragment (M30) as marker of postoperative residual tumor load in colon cancer patients.
    Ausch C; Buxhofer-Ausch V; Olszewski U; Hinterberger W; Ogris E; Schiessel R; Hamilton G
    Eur J Surg Oncol; 2009 Nov; 35(11):1164-8. PubMed ID: 19254831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of serum M30 and M65 activity in patients with stage-I endometrial cancer.
    Camuzcuoğlu A; Sezgin B; Çelik H; Camuzcuoğlu H
    J Obstet Gynaecol; 2019 Nov; 39(8):1112-1116. PubMed ID: 31177876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of serum cell death biomarkers for diagnosing biliary tract cancer.
    Sugimoto M; Abe K; Hayashi M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hashimoto M; Hikichi T; Nozawa Y; Ohira H
    Sci Rep; 2018 Nov; 8(1):16997. PubMed ID: 30451962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression of serum M30 and M65 in chronic hepatitis B patients with non-alcoholic fatty liver disease.
    Liang J; Han T; Gao YT; Jing L; Ma Z
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4123-9. PubMed ID: 26592838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total Keratin-18 (M65) as a Potential, Early, Non-Invasive Biomarker of Hepatocyte Injury in Alcohol Intoxicated Adolescents-A Preliminary Study.
    Zdanowicz K; Olanski W; Kowalczuk-Kryston M; Bobrus-Chociej A; Werpachowska I; Lebensztejn DM
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serial changes in circulating M30 antigen, a biomarker of apoptosis, in patients with acute coronary syndromes: relationship with the severity of coronary artery disease.
    Senturk T; Aydinlar A; Yilmaz Y; Oral AY; Ozdabakoglu O; Ulukaya E
    Coron Artery Dis; 2009 Dec; 20(8):494-8. PubMed ID: 19770641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokeratin 18 cell death assays as biomarkers for quantification of apoptosis and necrosis in COVID-19: a prospective, observational study.
    Henry BM; Cheruiyot I; Benoit SW; Sanchis-Gomar F; Lippi G; Benoit J
    J Clin Pathol; 2022 Jun; 75(6):410-415. PubMed ID: 33789919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.